Related Experiment Videos
Acanthocytosis and neurological disorders
1Department of Neurology, Atkinson Morley's Hospital, Copse Hill, Wimbledon, London, SW20 0NE, UK. rhardie@sghms.ac.uk
Journal of Neurology
|April 4, 2001
Summary
Acanthocytosis, a condition with red blood cell membrane abnormalities, is linked to several hereditary neurological disorders. Understanding these conditions, including abetalipoproteinaemia, neuroacanthocytosis, and McLeod syndrome, is crucial for developing effective treatments.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Acanthocytosis involves red blood cell membrane abnormalities, leading to reduced fluidity.
- At least three hereditary neurological conditions are associated with acanthocytosis, but their pathogenesis remains unclear.
Purpose of the Study:
- To review the hereditary neurological conditions associated with acanthocytosis.
- To highlight the clinical features and genetic basis of these disorders.
- To emphasize the potential of molecular genetics in understanding disease mechanisms and treatment.
Main Methods:
- Literature review of hereditary neurological conditions associated with acanthocytosis.
- Analysis of clinical presentations and genetic inheritance patterns.
- Discussion of current understanding and future research directions.
Main Results:
- Abetalipoproteinaemia: Autosomal recessive, vitamin E deficiency, spinocerebellar syndrome, peripheral neuropathy, retinitis pigmentosa.
- Neuroacanthocytosis: Likely autosomal recessive, characterized by chorea, orofaciolingual dyskinesia, dysarthria, seizures, and dementia.
- McLeod syndrome: X-linked recessive, typically benign myopathy with areflexia and abnormal Kell blood group antigen expression, but can present with severe neurological features.
Conclusions:
- Acanthocytosis is associated with distinct hereditary neurological disorders with varying genetic bases and clinical manifestations.
- Further research, particularly in molecular genetics, is essential for elucidating disease mechanisms and developing targeted therapies.